Literature DB >> 15517416

Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients.

Renee F Robinson1, Milap C Nahata, Elizabeth Sparks, Curt Daniels, Donald L Batisky, John R Hayes, John D Mahan.   

Abstract

There is ample evidence that the same pathophysiological processes that affect cardiovascular function in adults with end-stage renal disease (ESRD) also operate in children with ESRD. In adults undergoing hemodialysis (HD), a good correlation has been established between left ventricular mass (LVM) and aortic distensibility (AD) as markers of cardiovascular disease progression; however, this correlation has not been established in children. Therefore, in this retrospective study we investigated some aspects of cardiovascular damage (i.e., LVM, LVMI, and AD) in children with ESRD undergoing HD (n=9) or peritoneal dialysis (PD, n=9), and analyzed the relationship between AD, LVM, LVMI, pre-dialysis, post-dialysis blood pressure (BP), and demographic factors in children and adolescents with ESRD. Both LVM and AD were significantly greater in the dialysis population than in a control population derived from our institutional files (P=0.015, P=0.001). LVM and LVMI in children undergoing HD (92.9+/-83.7 g, 80.1+/-31.1 g/cm) were not statistically different from the values in children on PD (130.0+/-89.2 g, 89.6+/-35.9 g/cm), (P=0.3, P=0.5). AD in children on HD (2.2+/-0.55 cm2* dynes(-1*(10-6)) was significantly lower than in children on PD (2.7+/-0.54 cm2* dynes(-1*(10-6)), (P=0.01). The findings in this study confirm earlier studies that demonstrated that LVMI is greater in children on dialysis. This study also demonstrates that abnormal vascular stiffness, as defined by AD, is present in these children. The degree of vascular stiffness in children receiving HD is greater than in children receiving PD. However, further study is needed to address how control of BP, uremia, and other factors may affect these abnormalities in children with ESRD.

Entities:  

Mesh:

Year:  2004        PMID: 15517416     DOI: 10.1007/s00467-004-1667-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  47 in total

Review 1.  Pulse pressure, arterial stiffness, and drug treatment of hypertension.

Authors:  L M Van Bortel; H A Struijker-Boudier; M E Safar
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

2.  Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension.

Authors:  C W Belsha; T G Wells; K L McNiece; P M Seib; J K Plummer; P L Berry
Journal:  Am J Hypertens       Date:  1998-04       Impact factor: 2.689

3.  Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1996-10       Impact factor: 7.124

4.  Blood pressure measurements and left ventricular mass in young adults with arterial hypertension screened at high school check-up.

Authors:  B Chamontin; J Amar; P Barthe; M Salvador
Journal:  J Hum Hypertens       Date:  1994-05       Impact factor: 3.012

5.  Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.

Authors:  T Nishikimi; F Yoshihara; A Morimoto; K Ishikawa; T Ishimitsu; Y Saito; K Kangawa; H Matsuo; T Omae; H Matsuoka
Journal:  Hypertension       Date:  1996-07       Impact factor: 10.190

6.  Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients.

Authors:  G Cannella; E Paoletti; G Ravera; P Cassottana; P Araghi; D Mulas; G Peloso; R Delfino; P Messa
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

7.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

Authors:  M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

8.  Increased arterial stiffness in young adults with end-stage renal disease since childhood.

Authors:  Jaap W Groothoff; Mariken P Gruppen; Martin Offringa; Eric de Groot; Willem Stok; Willem Jan Bos; Jean Claude Davin; Marc R Lilien; Nicole Caj Van de Kar; Eric D Wolff; Hugo S Heymans
Journal:  J Am Soc Nephrol       Date:  2002-12       Impact factor: 10.121

9.  The prognostic importance of left ventricular geometry in uremic cardiomyopathy.

Authors:  R N Foley; P S Parfrey; J D Harnett; G M Kent; D C Murray; P E Barré
Journal:  J Am Soc Nephrol       Date:  1995-06       Impact factor: 10.121

10.  Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure.

Authors:  Jonathan M Sorof; Andrei V Alexandrov; Gina Cardwell; Ronald J Portman
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

View more
  10 in total

Review 1.  Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations.

Authors:  Peter N Van Buren; Jula K Inrig
Journal:  Pediatr Nephrol       Date:  2011-02-01       Impact factor: 3.714

Review 2.  A single gene connects stiffness in glaucoma and the vascular system.

Authors:  Teresa Borrás
Journal:  Exp Eye Res       Date:  2016-09-01       Impact factor: 3.467

3.  Reduction of left ventricular hypertrophy in children undergoing hemodialysis.

Authors:  Tim Ulinski; Julie Genty; Christine Viau; Isabelle Tillous-Borde; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2006-06-01       Impact factor: 3.714

4.  When does the cardiovascular disease appear in patients with chronic kidney disease?

Authors:  Betul Sozeri; Sevgi Mir; Orhan Deniz Kara; Erturk Levent
Journal:  Pediatr Cardiol       Date:  2010-04-17       Impact factor: 1.655

5.  Relationship between elevated arterial stiffness and increased left ventricular mass in adolescents and young adults.

Authors:  Elaine M Urbina; Lawrence M Dolan; Connie E McCoy; Philip R Khoury; Stephen R Daniels; Thomas R Kimball
Journal:  J Pediatr       Date:  2011-05       Impact factor: 4.406

6.  Maps of Ventricular Activation Time (VAT) Differences in Children on Peritoneal Dialysis - a Pilot Study.

Authors:  Krystyna Laszki-Szcząchor; Dorota Polak-Jonkisz; Danuta Zwolińska; Ewa Salomon; Henryk Filipowski; Małgorzata Sobieszczańska
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

7.  Evaluation of aortic stiffness in children with chronic renal failure.

Authors:  Ali Rahmi Bakiler; Onder Yavascan; Nilgun Harputluoglu; Orhan Deniz Kara; Nejat Aksu
Journal:  Pediatr Nephrol       Date:  2007-08-21       Impact factor: 3.714

8.  Relation of thoracic aortic distensibility to left ventricular area (from the Multi-Ethnic Study of Atherosclerosis [MESA]).

Authors:  Mouaz H Al-Mallah; Khurram Nasir; Ronit Katz; Joao A Lima; David A Bluemke; Roger S Blumenthal; Songshou Mao; W Gregory Hundley; Matthew J Budoff
Journal:  Am J Cardiol       Date:  2013-10-08       Impact factor: 2.778

9.  Heart ventricular activation in VAT difference maps from children with chronic kidney disease.

Authors:  Krystyna Laszki-Szcząchor; Dorota Polak-Jonkisz; Danuta Zwolińska; Lesław Rusiecki; Anna Janocha; Małgorzata Sobieszczańska
Journal:  Pediatr Nephrol       Date:  2011-08-11       Impact factor: 3.714

10.  Association of Trimethylamine, Trimethylamine N-oxide, and Dimethylamine with Cardiovascular Risk in Children with Chronic Kidney Disease.

Authors:  Chien-Ning Hsu; Guo-Ping Chang-Chien; Sufan Lin; Chih-Yao Hou; Pei-Chen Lu; You-Lin Tain
Journal:  J Clin Med       Date:  2020-01-25       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.